Skip to main content

J. Wallace Parce

Ontera, a Santa Cruz, California-based firm developing silicon-based nanopore diagnostics, has appointed J. Wallace Parce to its advisory board. He has cofounded and held senior positions at a number of life science technology companies including Nanosys, Caliper Technologies, and Molecular Devices. 

Parce was an associate professor at Wake Forest University's medical school and also received his doctorate from that university.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.